Royal Fund Management »

SPDR S&P Biotech shares owned by Royal Fund Management

Quarter-by-quarter ownership of SPDR S&P Biotech (XBI) shares owned by Royal Fund Management from 13F filings

Historical chart of Royal Fund Management investment in SPDR S&P Biotech

Tip: Access up to 7 years of quarterly data

All positions including SPDR S&P Biotech held by Royal Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in SPDR S&P Biotech by Royal Fund Management

Quarter filed Position value Share count Share price at filing
2024-09-30 $29M 297k 98.80
2024-06-30 $5.6M 61k 92.71
2017-12-31 $8.0k 102 78.43

More positions owned by Royal Fund Management

Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Russell 2000 Etf (IWM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
NVIDIA Corporation (NVDA)
Vanguard World Inf Tech Etf (VGT)
Select Sector Spdr Tr Financial (XLF)
Spdr Ser Tr S&p Biotech (XBI)
Microsoft Corporation Call Option (MSFT)
Ishares Tr Ishares Semicdtr (SOXX)
Select Sector Spdr Tr Sbi Healthcare (XLV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr S&P SML 600 GWT (IJT)
Uber Technologies Call Option (UBER)
Ishares Tr Core S&p Scp Etf (IJR)

View all positions for Royal Fund Management

Top funds holding SPDR S&P Biotech

Goldman Sachs Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Bank of America Corporation
Citigroup
Jane Street
Citadel Advisors
Morgan Stanley
Susquehanna International
NWI Management
Bnp Paribas Arbitrage, Snc
Twin Tree Management
Parallax Volatility Advisers
Wells Fargo & Company
Logos Global Management

View all funds holding SPDR S&P Biotech